N-(1-[[5-(tert-butyl)-1,3,4-oxadiazol-2-yl]carbonyl]-2-methylpropyl)-2-[5-nitro-6-oxo-2-phenyl-1(6H)-pyrimidinyl]acetamide -Drug Synthesis Database

【结构式】

【分子编号】47824

【品名】N-(1-[[5-(tert-butyl)-1,3,4-oxadiazol-2-yl]carbonyl]-2-methylpropyl)-2-[5-nitro-6-oxo-2-phenyl-1(6H)-pyrimidinyl]acetamide

【CA登记号】

【分子式】C₂₃H₂₆N₆O₆

【分子量】482.49628

【元素组成】C 57.25% H 5.43% N 17.42% O 19.9%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号：(XIV)

The condensation of intermediate acetic acid (IV) with 2-tert-butyl-5-(DL-valyl)-1,3,4-oxadiazole (XIII) by means of methyl chloroformate and NMM gives the corresponding amide (XIV), which is finally reduced with H2 over Pd/C in MeOH.

参考文献中间体

合成目标

【1】 Yamamoto, T.; Okuma, M.; Ohmoto, K.; et al.; Development of orally active nonpeptidic inhibitors of human neutrophil elastase. J Med Chem 2001, 44, 8, 1268.
【2】 Okada, T.; Hachiya, K.; Motoi, T.; Kojima, T.; Hashimoto, S. (Ono Pharmaceutical Co., Ltd.); Pyrimidine derivs., process for preparing the derivs. and drugs containing the same as the active ingredient. WO 0123361 .

中间体序号	中间体编号	品名	分子式	供应商	用于合成
(IV)	47814	2-[5-nitro-6-oxo-2-phenyl-1(6H)-pyrimidinyl]acetic acid	C₁₂H₉N₃O₅	详情	详情
(XIII)	47823	2-amino-1-[5-(tert-butyl)-1,3,4-oxadiazol-2-yl]-3-methyl-1-butanone	C₁₁H₁₉N₃O₂	详情	详情
(XIV)	47824	N-(1-[[5-(tert-butyl)-1,3,4-oxadiazol-2-yl]carbonyl]-2-methylpropyl)-2-[5-nitro-6-oxo-2-phenyl-1(6H)-pyrimidinyl]acetamide	C₂₃H₂₆N₆O₆	详情	详情

Extended Information